scout
|Videos|September 23, 2020

Practical Management of Early Stage HER2+ Breast Cancer

Nurse practitioners provide insight on issues surrounding the administration of dual HER2-targeted therapy in the neoadjuvant/adjuvant setting and counseling patients on common AEs associated with trastuzumab-pertuzumab for the treatment of HER2+ breast cancer.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME